It has been proposed that the hypothalamus helps to control ageing, but the mechanisms responsible remain unclear. Here we develop several mouse models in which hypothalamic stem/progenitor cells that co-express Sox2 and Bmi1 are ablated, as we observed that ageing in mice started with a substantial loss of these hypothalamic cells. Each mouse model consistently displayed acceleration of ageing-like physiological changes or a shortened lifespan. Conversely, ageing retardation and lifespan extension were achieved in mid-aged mice that were locally implanted with healthy hypothalamic stem/progenitor cells that had been genetically engineered to survive in the ageing-related hypothalamic inflammatory microenvironment. Mechanistically, hypothalamic stem/progenitor cells contributed greatly to exosomal microRNAs (miRNAs) in the cerebrospinal fluid, and these exosomal miRNAs declined during ageing, whereas central treatment with healthy hypothalamic stem/progenitor cell-secreted exosomes led to the slowing of ageing. In conclusion, ageing speed is substantially controlled by hypothalamic stem cells, partially through the release of exosomal miRNAs.
Although the nervous system clearly has a role in ageing 1-6 , and research has demonstrated that the hypothalamus is particularly important 5-8 , the cellular mechanism responsible for ageing is still unknown. It has been shown that adult neural stem/progenitor cells (NSCs) reside in a few brain regions that mediate local neurogenesis and therefore several aspects of brain functioning [9] [10] [11] [12] [13] . Studies on adult neurogenesis have focused on the hippocampus and the subventricular zone of the lateral ventricle in the brain [9] [10] [11] [12] [13] . Decreased neurogenesis in these regions often correlates with the advent of related ageing-associated disorders 10, [14] [15] [16] [17] [18] . More recently, it has been shown that adult NSCs are present in the hypothalamus [19] [20] [21] , in particular in the mediobasal hypothalamic region (MBH), which is crucial for the neuroendocrine regulation of the physiological homeostasis of the whole body. We have previously shown that the hypothalamus has a programmatic role in causing systemic ageing 5 . In this context, we investigated whether these hypothalamic NSCs (htNSCs) might be mechanistically responsible for this process.
Ageing-associated htNSC loss
Sox2 is a nuclear transcription factor that is strongly expressed in NSCs and has often been used to label NSCs 22 . We have found that, in adult mice, Sox2 is expressed in a population of cells in the MBH and especially in the hypothalamic third-ventricle wall within the MBH 19 . To gain an insight into their relevance to ageing, we comparatively examined these hypothalamic cells during ageing. Together with Sox2, we analysed the Polycomb complex protein Bmi1 (BMI1 in humans (B lymphoma Moloney murine leukaemia virus integration site 1 homologue))-a nuclear protein that is essential for self-renewal of NSCs and haematopoietic stem cells 23 . As shown in Fig. 1a , cells coexpressing Sox2 and Bmi1 were found to be densely present in the hypothalamic third-ventricle wall, whereas they were sporadically present in the MBH parenchyma of young mice. These cells gradually diminished with increased age, starting from the bottom part of the MBH of the hypothalamic third-ventricle wall in early-to mid-aged mice (11-16 months old) and becoming almost entirely lost in aged mice (22 months and older) . We also examined nestin, which, although it is not NSC specific, is known to be strongly expressed in NSCs and their offspring progenitors 20, 24, 25 . To focus on the hypothalamic thirdventricle wall, we confirmed that nestin + cells in this region greatly decreased with age ( Fig. 1b ). In addition, because Musashi1 and Cxcr4 were also reported as NSC biomarkers 24, 26 , we examined both of these markers and found that the number of cells that were positive for Musashi1 and Cxcr4 in the hypothalamic third-ventricle wall decreased markedly during ageing. Moreover, through BrdU tracking, we confirmed that BrdU + cells were present in the hypothalamic third-ventricle wall of young mice, but were barely detected in this region in mid-aged mice (data not shown). Overall, the time course of age-dependent loss of htNSCs correlated well with ageing-related physiological declines (Extended Data Fig. 1 ), leading us to investigate whether the loss of these cells could be causally important for ageing.
Ageing acceleration due to htNSC loss
Because the hypothalamic third-ventricle wall is the area that sensitively undergoes loss of NSCs, we mimicked this change by experimentally ablating NSCs in this region. To do so, we adopted the approach of viral injection into the hypothalamic third ventricle, especially because the injected lentiviruses preferentially infected the third-ventricle surface, which contains the NSCs, but hardly penetrated the wall to infect the parenchyma (Extended Data Fig. 2a ). Also, injected lentiviruses did not travel to distant regions, such as the lateral ventricle (Extended Data Fig. 2a ). We ablated htNSCs by injection of lentiviruses that expressed herpes simplex virus thymidine kinase-1 (Hsv-TK1) controlled by a Sox2 promoter and by subsequently applying Ganciclovir (GCV), which is converted into a toxin by TK1. Therefore, TK1-expressing Sox2 cells in the hypothalamic third-ventricle wall were partially ablated. This treatment eventually led to a 70% loss of Sox2 cells in the hypothalamic third-ventricle wall of mice injected with both TK1 and GCV (hereafter TK1/GCV), without a major effect on parenchymal Sox2 cells or neurons ( Fig. 1c-e ). For this model, we separately analysed MBH neuronal subtypes, POMC and AgRP neurons, using POMC-Cre and AgRP-Cre mouse stains. TK1/GCV treatment did not decrease the number of these neurons (Extended Data Fig. 2b, c) , and functionally optogenetic stimulation of each of these neuronal subtypes led to comparable feeding responses for TK1/GCV-injected mice and controls (Extended Data Fig. 2d ). To study ageing-related physiology, the TK1/GCV model and various control groups were used at a midage. Compared to control groups over an approximately 3-4-month follow-up, TK1/GCV mice displayed accelerated decreases in muscle endurance, coordination, treadmill performance, sociality and novel object recognition ( Fig. 1f ). Analysis of the performance in the Morris water maze test showed that TK1/GCV-injected mice manifested a cognitive decline more than the controls did ( Fig. 1f and Extended Data Fig. 2e ). In comparison with the regular speed of ageing progression in wild-type C57BL/6 mice (Extended Data Fig. 1 ), all of these physiological changes in TK1/GCV-injected mice reflected an acceleration in ageing.
In parallel, we used an alternative cell-ablation method to test whether it could reproduce the pro-ageing phenotype of the TK1/GCV model. A previous study 27 has shown that the expression of inducible diphtheria toxin receptor (DTR) followed by the administration of diphtheria toxin led to cell ablation in these mice. Therefore, we generated lentiviruses that expressed DTR controlled by the Sox2 promoter, as indicated in Extended Data Figure 3a , b. We then injected this DTR lentivirus or a control lentivirus into the hypothalamic third ventricle of mid-aged mice, followed by diphtheria toxin administration to activate DTR. This approach resulted in a significant ablation of Sox2 cells in the hypothalamic third-ventricle wall, while MBH parenchymal cells were barely affected (Extended Data Fig. 3c, d ). Indeed, DTR and diphtheria toxin treatment gradually led to accelerated physiological declines (Extended Data Fig. 3e ), similar to what was seen in the TK1/GCV model described above.
Additional experiments were performed through intra-MBH viral injection, which led to the restriction of htNSC ablation to the MBH part of the third-ventricle wall and the MBH parenchyma. Similar to the Sox2-promoter-based targeting in Figure 1 , we used a Bmi1 promoter to direct TK1 expression. We delivered the TK1 or control lentiviruses bilaterally into the MBH of mid-aged mice ( Fig. 2a) , which led to a significant loss of NSCs in the MBH portion of the third-ventricle wall and the parenchyma (Fig. 2b, c) , whereas the number of neurons in the MBH did not decrease ( Fig. 2d ). Compared to controls over a 3-4-month follow-up, TK1/GCV-injected mice clearly showed ageing-like physiological declines ( Fig. 2e -h), cognitive impairment ( Fig. 2i , j) and injection, the TK1 + /GCV + group (labelled as TK1/GCV) was compared to control groups (data derived from the TK1 + /GCV − group, but also representative of TK1 − /GCV + and TK1 − /GCV − groups) for physiology (e-j) and histology (k). Images represent two independent experiments. Scale bars, 100 μ m. l-n, Male C57BL/6 mice (8 months old) were bilaterally injected in the MBH with Sox2-promoter-driven Hsv-TK1 (TK1) or control lentiviruses, followed by GCV treatment. l, Diagram of TK1 lentivirus and injection in the MBH. m, Sox2 + cells in MBH parenchyma and hypothalamic third-ventricle wall of mice injected with TK1/GCV (age-matched uninjected mice are included as a reference). n, Lifespan follow-up. * P < 0.05, * * P < 0.01, * * * P < 0.001; two-tailed Student's t-test (b-k), two-way ANOVA with post hoc test (m), log-rank (Mantel-Cox) test (n); n = 4 mice (b, c, m), n = 5 mice (d) and n = 6 mice (e-k) per group, and n = 19 mice for control and n = 20 mice for TK1 (n). Data are mean ± s.e.m.
Article reSeArcH histopathology (Fig. 2k ). In addition, we set up a cohort of 8-monthold mice that were injected with TK1 or control lentiviruses for a lifespan follow-up. This model was based on Sox2-promoter-driven TK1 expression and MBH injection ( Fig. 2l , m). As shown in Figure 2n , there was a significant decrease in the lifespan of TK1/GCV-treated mice compared to controls. Hence, results from these additional models consistently indicate that the MBH is essential for the role of htNSCs in controlling the speed of ageing.
Slowdown of ageing by implantation of Iκ Bα -htNSCs
We simultaneously investigated whether htNSCs could be implanted into the MBH to slow down the progression of ageing. For the initial trial, we used a line of htNSCs derived from newborn mice that were labelled with GFP by lentiviral induction as has been described previously 19 and injected these cells into the MBH of mid-aged mice. However, these NSCs survived poorly after injection. This failure could be related to an inflammatory hypothalamic environment 5 , as we have shown that hypothalamic inflammation is harmful for htNSCs 19 . Therefore, we asked whether inhibition of the inflammatory response in these cells might help to overcome this survival problem. To do so, we used htNSCs derived from newborn mice that stably expressed dominant-negative Iκ Bα and GFP (Iκ Bα -htNSCs). We have previously shown that these cells are resilient to NF-κ B-mediated inflammation, compared to control htNSCs that stably expressed GFP (control-htNSCs) 19 . We implanted the same number of Iκ Bα -htNSCs or control-htNSCs into the MBH of mid-aged mice. Iκ Bα -htNSCs demonstrated a pronounced improvement in survival ( Fig. 3a) , showing that around 50% of grafted Iκ Bα -htNSCs were alive, whereas few grafted control-htNSCs were found at two months after implantation. Then, we set up a group of mid-aged C57BL/6 mice that were bilaterally injected in the MBH with Iκ Bα -htNSCs to study ageing-related physiology. For comparison, in addition to vehicle injection, a group of age-matched mice was injected with the same number of hypothalamic astrocytes. Hypothalamic astrocytes were derived from newborn mice, cultured and confirmed by immunostaining for the presence of the astrocyte marker S100B and the absence of NSC markers. In addition, we included mesenchymal stem cells (MSCs) as another type of comparison, because MSCs represent stem cells from a different embryonic origin. All cells were genetically labelled with GFP, and the same number of cells was bilaterally injected. Of note, astrocytes and MSCs were relatively insensitive to ageing-associated hypothalamic inflammation, because without genetic anti-inflammatory manipulation these cells survived to a level that was comparable to Iκ Bα -htNSCs ( Fig. 3b ). Compared to vehicle controls, implanted Iκ Bα -htNSCs led to a battery of systemic benefits, which were already recognizable at six weeks after implantation and continued to be more appreciable at four months after implantation ( Fig. 3c ). By contrast, no effects were identified after the implantation of astrocytes or MSCs (Fig. 3c ). Independently, we generated separate groups of mid-aged mice injected in the MBH with Iκ Bα -htNSCs for lifespan follow-up, while the control groups were injected with control-htNSCs or vehicle. Control-htNSCs did not induce a significant change in lifespan compared to vehicle control (data not shown), consistent with the fact that these cells did not survive long enough. By contrast, consistent with the anti-ageing effects ( Fig. 3c ), mice injected with Iκ Bα -htNSCs demonstrated an increase in lifespan ( Fig. 3d ). To summarize, a local restoration of htNSCs in mid-aged mice can provide a substantial anti-ageing and longevity effect.
Endocrine secretion of exosomal miRNAs by htNSCs
As described above, the modulation of ageing by htNSCs, when ablated or implanted, was observable in a relatively short period (three to four months), therefore we reasoned that an endocrine function rather than neurogenesis of these cells was responsible. Considering that the pool of htNSCs is small, yet the effects on modulating of ageing are remarkable, we asked whether these cells might secrete substances that could have multifaceted functions. We considered exosomal miRNAs, because miRNAs have been linked to stem cell function 28, 29 as well as to ageing 30 . Our prediction was supported by immunostaining for the exosomal protein CD81 and electron microscopic analysis, which showed that granule-like structures (Extended Data Fig. 4a ) and multivesicular bodies (Extended Data Fig. 4b ) were abundantly present in htNSCs, but were poorly detected in astrocytes from the same hypothalamus. Then, we isolated exosomes that were secreted from cultured htNSCs, as verified through a list of assays, including western blotting ( Fig. 4a ), flow cytometry (Extended Data Fig. 4c ) and nanoparticle analysis ( Fig. 4b and Extended Data Fig. 4d ). The secreted exosomes that we isolated were also subjected by fractioning using density gradient ultracentrifugation or pull-down using the anti-CD81 antibody (Extended Data Fig. 5 ), both analyses confirmed that miRNAs were detected in the exosome fractions. Nanoparticle analysis was further used to compare exosomes secreted from htNSCs or other cells ( Fig. 4b) , showing that exosomes secreted from htNSCs were notably more abundant compared to exosomes secreted by astrocytes, GT1-7 cells and MSCs. Using the Qubit RNA assay to quantify exosomal RNA, we found that secreted exosomes of htNSCs contained a large amount of RNA. We analysed the miRNA in these secreted exosomes, showing that miRNA produced by htNSCs was more abundant than miRNA produced by hippocampal NSCs, and the production by htNSCs was approximately 100-fold higher than by hypothalamic astrocytes, GT1-7 cells and MSCs ( Fig. 4c and Extended Data Fig. 6a, b ). Subsequently, we profiled exosomal miRNAs secreted by these different cells using microarray affymetrix chips, showing that htNSCs were most strongly capable of the secretion of exosomal miRNAs (Fig. 4d ). 
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Despite the fact that hippocampal NSCs also greatly produced exosomes, the amount of exosomal miRNA from these cells was lower and the pattern of miRNA secretion was different to htNSCs ( Fig. 4e ). Therefore, htNSCs have a notable endocrine function of secreting exosomal miRNAs.
Contribution of htNSCs to exosomal miRNAs in the brain
Using information from miRNA microarray affymetrix chips ( Fig. 4d ), we analysed miRNAs in the cerebrospinal fluid (CSF) samples collected from young or mid-aged mice. Focusing on miRNA species that are abundantly produced by htNSCs, we found that over 20 miRNA species were substantially decreased in the CSF of mid-aged mice (Fig. 5a ). To test whether the reduction in these miRNAs in the CSF of mid-aged mice could be due to ageing-associated loss of htNSCs, we designed an experiment in which exosomal secretion of htNSCs was genetically inhibited. To do so, we created a lentivirus containing a Cre-dependent shRNA against Rab27a, a key molecule for the function of exosomal secretion. Through co-infection with a Sox2-promoter-driven Cre lentivirus, and using two independent shRNA sequences against Rab27a mRNA, we confirmed that this approach led to reduced secretion of exosomal miRNAs in cultured htNSCs (Fig. 5b ). In addition, we analysed a list of growth factors and cytokines and found that Rab27a shRNA did not affect the secretion of a majority of these peptide hormones from htNSCs (Extended Data Fig. 7 ). This inhibitory effect on exosomal release by Rab27a shRNA was not a result of cell loss, as Rab27a shRNA did not immediately affect the survival or proliferation of these cultured cells (Extended Data Fig. 8a, b ). Therefore, we injected the Sox2-Cre lentivirus together with Rab27a shRNA or a control shRNA lentivirus into the hypothalamic third-ventricle of young mice. One week later, CSF samples were examined, showing that Rab27a shRNA resulted in decreases in many miRNAs in the CSF (Fig. 5c ). We applied this approach to mid-aged mice and analysed ageingrelated physiology at six weeks after injection, during which Rab27a shRNA did not yet cause a reduction in htNSCs (but it did so over a long duration, such as three months). As shown in Extended Data Figure 8c , mice injected with Rab27a shRNA showed impairments in several aspects of physiology, although to a lower extent compared to the models of cell ablation.
Slowdown of ageing by htNSC-derived exosomes
The results above support a role for exosomal secretion from htNSCs for the control of ageing. We decided to focus this work on htNSCsecreted exosomes, although we also predict that neuropeptide secretion by these cells is relevant, especially in the context of our previous study which showed that GnRH is involved in hypothalamic control of ageing 5 , and indeed we observed in this work by using immunostaining that some implanted htNSCs became GnRH-positive Article reSeArcH cells (data not shown). Therefore, we tested whether ageing could be slowed down by treatment with htNSC-secreted exosomes that were purified and verified by electron microscopy (Extended Data Fig. 9 ). First, following the observation that exosomal miRNAs are transferrable among htNSCs (Fig. 6a ), we confirmed that central treatment with these exoxomes in mid-aged mice helped maintain htNSCs (Fig. 6b) , and that this effect was associated with a reduction in hypothalamic inflammation (Extended Data Fig. 10a ). Then, physiological experiments were performed, using an NSC-ablation-induced ageing model and a normal ageing model. To do so, mid-aged mice with TK1/GCV-induced ablation of htNSCs, as described in Figure 2 , received a three-month treatment with secreted exosomes purified from cultured htNSCs, which had been derived from newborn mice. Whereas TK1/GCV-induced ablation of NSCs in the control group led to pro-ageing effects, many of these changes were ameliorated by the treatment with exosomes ( Fig. 6c and Extended Data Fig. 10b ). These anti-ageing effects were not a result of food intake change, as these mice ate similar amounts as the controls. In parallel, we performed an experiment in which mid-aged C57BL/6 mice were treated with exosomes or vehicle for four months. Compared to the vehicle-treated group, which showed many ageing-associated disorders, exosome-treated mice developed these problems to a much lower extent ( Fig. 6d and Extended Data Fig. 10c ), and these protective effects were also independent of food intake. On the basis of these therapeutic experiments, we show that exosomal miRNAs are important for the role of htNSCs in the control of ageing.
Discussion
We show that loss of htNSCs is an important cause of ageing in the whole body. This understanding aligns with our previous research showing that the hypothalamus has a programmatic role in systemic ageing 5 . The underlying basis could be related to two functions of these cells: endocrine secretion and neurogenesis. Here we report that the modulation of ageing by htNSCs was achieved in a relatively short period, which should not have a major contribution from neurogenesis, while an endocrine function of these cells provided a neurogenesisindependent mechanism. In this context, we show that the anti-ageing effect of htNSCs is partially mediated by exosomal miRNAs secreted from these cells. Therefore, besides the classical endocrine function of the hypothalamus in secreting peptidyl hormones, htNSCs have a new type of endocrine function by secreting exosomal miRNAs. Given this finding, we still predict that neuropeptide secretion by htNSCs, although not addressed in this work, also participates in the regulation of systemic ageing. This is partly because we previously found that GnRH is involved in the hypothalamic control of ageing 5 and we observed here that some implanted htNSCs gave rise to GnRHexpressing cells. Thus, neuropeptide-based endocrine functions of htNSCs and their differentiated offsprings can contribute to the anti-ageing effects of these cells from other perspectives. Despite these outstanding questions, the overall findings in this work support that htNSCs are essential for the control of ageing speed.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. 
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MethOdS
Cell culture. Primary culture of NSCs was performed as described previously 19 . In brief, the hypothalamus and hippocampus were dissected from newborn C57BL/6 mice, cut into small pieces (approximately 1 mm 3 ), and followed by digestion using TrypLE Express enzyme (Life Technologies) for 30 min at 37 °C. After centrifugation, cells were suspended in NSC medium composed of neurobasal-A (Life Technologies), 0.24% GlutaMAX supplement (Life Technologies), 2% B27 without vitamin A (Life Technologies), 10 ng ml −1 EGF (Sigma-Aldrich), 10 ng ml −1 bFGF (Life Technologies) and 1% penicillin-streptomycin and seeded in ultralow-adhesion 6-well plates (Corning). One week later, neurospheres were collected by centrifugation and trypsinized with TrypLE Express enzyme into single cells, passaged and maintained in neurosphere culture until experimental use. Hypothalamic astrocytes were isolated from newborn C57BL/6 mice as described previously 31 . In brief, the hypothalamus of newborn mice was dissected, the meninges were removed and cells were dissociated in 0.05% trypsin-EDTA. Mixed cells were cultured at 37 °C in 5% CO 2 . Non-adherent cells were removed by changing the medium every two to three days. After 7-10 days, cells were shaken vigorously in an orbital incubator at 0.23g at 37 °C for 2 h to detach microglia, then shaken at 0.23g at 37 °C overnight to remove oligodendrocytes. Remaining cells were most astrocytes and were trypsinized and reseeded for further culture. HEK293T cells were purchased from ATCC (CRL-3216), and GT1-7 cells were established as previously reported 32 . HEK293T cells, GT1-7 cells and astrocytes were cultured in Dulbecco's modified Eagle medium (DMEM) containing 10% fetal bovine serum and 1% penicillin-streptomycin. Mesenchymal stem cells were isolated from 6-8-week-old C57BL/6 mice as described previously 33 . In brief, bone marrow cells were flushed out of the femurs and tibias, and cultured in DMEM containing 15% fetal bovine serum and 1% penicillin-streptomycin at 37 °C in 5% CO 2 . After 3 h, medium was changed to remove non-adherent cells. After 1-2 weeks of culture, cells reached confluence and were passaged for subsequent experiments. All cell lines used in this study were free of microbial (including mycoplasma) contamination and their morphology and growth characteristics were compared to published information to ensure their authenticity. Plasmids and recombinant lentiviruses. The lentiviral vector of Sox2-promoterdriven Hsv-TK1 and matched control were generated as reported previously 34 . The lentiviral vector of Bmi1-promoter-driven TK1 was generated by replacing the Sox2 promoter with the Bmi1 promoter in the above TK1 plasmid. The lentiviral vector of Sox2-promoter-driven DTR was generated by replacing TK1 cDNA with the coding sequence of simian DTR in the plasmid of Sox2-promoterdriven TK1. Mouse Rab27a shRNA and scramble shRNA were constructed using the vector pSico (Addgene). Rab27a shRNA-1, GGAGAGGTTTCGTAGCTTA; Rab27a shRNA-2, GCTTCTGTTCGACCTGACA; scramble shRNA, ATCTCGCTTGGGCGAGAGT. Plasmids of rAAV2-FLEX-rev-ChR2:tdTomato were purchased from Addgene. Lentiviruses were produced by transfecting viral plasmids and packaging plasmids into HEK293T cells, purified by ultracentrifugation and titrated using the p24 ELISA kit as described previously 32 . Lentiviral infection and miRNA transfection. Lentiviral infection of the cells was performed by adding purified lentiviruses into culture medium for 24 h, before the medium was replaced. Synthetic miRNAs were purchased from Qiagen, including miR-106a-5p, miR-20a-5p and miR-466m-5p, and labelled with Cy3 using the Silencer siRNA labelling kit (Thermo Fisher Scientific, AM1632). Subsequently, 5 μ g of miRNA was incubated for 1 h in the dark followed by precipitation of miRNAs by adding ethanol and NaCl. Cy3-labelled miRNAs were transfected into cells using the HiPerFect Transfection Reagent (Qiagen). Cultured cell immunostaining. Cells were fixed with 4% PFA, blocked with the serum of appropriate species, permeabilized with 0.2% Triton X-100, and incubated with primary antibodies, followed by AlexaFluor 488-, 555-or 633-conjugated secondary antibodies (Invitrogen). Images were captured using a confocal microscope, and counting analysis included at least three coverslips per group and multiple areas per slide on a randomized basis. Primary antibodies included rabbit anti-Sox2 (Millipore, AB5603), rabbit anti-CD81 (Santa Cruz, sc-9158), mouse anti-DTR (Abcam, ab92620), and rabbit anti-Ki67 (Abcam, ab15580) antibodies. Electron microscopy. Electron microscopy was performed at the St. Giles Foundation Advanced Microscopy Center, Cold Spring Harbour Laboratory. Cells were cultured in laminin-coated 35-mm polystyrene dishes and fixed in 2% glutaraldehyde in 0.1 mol l −1 PBS. Cells were post-fixed in situ with 1% osmium tetroxide and 1.5% potassium ferrocyanide in distilled water for 1 h. Cells were then dehydrated in a grade series of ethanol and infiltrated with 50% epon-araldite resin (Sigma-Aldrich) for 1 h and then infiltrated for 2 h in 100% resin. Petri dishes were then filled with fresh resin and placed in a 600 °C oven overnight. The polystyrene of the Petri dish was sawn off from the edges of the dish and the disk was plunged repeatedly in liquid nitrogen using differences in thermal expansion to peel off the polystyrene on the bottom of the dish from the epoxy block.
The embedded cells were then with the mounted attachment-surface upwards in an ultramicrotome chuck and thin-sectioned at 100 nm. Thin-sections were counterstained with lead citrate and examined in a Hitachi H7500 transmission electron microscope. Representative areas were recorded on Kodak 4489 negative film (Electron Microscopy Sciences) that was then scanned at 2,400 DPI using an Epson V750 Pro scanner. Exosome isolation and analyses. Secreted exosomes in culture medium were purified by differential centrifugation as described previously 35 . In brief, culture medium was processed by ultracentrifugation at 4 °C overnight to remove particles to generate exosome-free medium. Cells were cultured in exosome-free medium for two days, after which the medium was collected, centrifuged to remove cells, immediately followed by exosome isolation in 4 °C. Exosome-containing medium was centrifuged and filtered to remove debris and particles. Exosomes in the filtered medium were isolated by differential centrifugation. Uncultured medium of the same volume was processed with the same purification procedures and used as a technical control. Isolated exosomes were assessed according to a list of different approaches. (1) Exosomal protein marker immunoblot: exosomal and cellular proteins were loaded and separated by SDS-PAGE, followed by western blotting with primary antibodies, including mouse anti-TSG101 (Santa Cruz, sc-7964), rabbit anti-CD81 (Santa Cruz, sc-9158), rabbit anti-AGO2 (Cell Signaling, 2897), rabbit anti-HSP90B1 (Cell signaling, 2104), mouse anti-GM130 (Santa Cruz, sc-55591), and rabbit anti-Cyc1 (Cell Signaling, 4272). Silver staining was performed using the ProteoSilver Silver Stain Kit (Sigma-Aldrich).
(2) Flow cytometry: purified exosomes were incubated with latex beads (Life technologies) for 15 min, adjusted to a final volume, and rotated at room temperature for 2 h, after which glycine was added. After incubation, beads were collected by centrifugation, resuspended and FACS staining was carried out using FITC-conjugated anti-CD81 (ThermoFisher, MA5-17939) antibody. (3) Nanoparticle tracking: purified exosomes were run on NanoSight (Malvern Instruments). These experiments were performed in the Center for Nanotechnology in Drug Delivery at University of North Carolina. (4) Density-gradient ultracentrifugation analysis: isolated exosomes were resuspended in 2.5 M sucrose solution (20 mM HEPES, pH7.4), plated with a continuous sucrose gradient from 2 M to 0.25 M, and ultracentrifuged overnight at 4 °C. Different fractions were collected, each fraction recovered by ultracentrifugation and analysed by immunoblot and real-time PCR. (5) Pulldown assay: anti-CD81 and isotype-control antibodies were coated onto Protein G beads (Life Technologies, 10003D), exosomes were re-suspended in PBS, which contained 3 mg ml −1 BSA, and incubated with antibody-coated beads overnight with rotation at 4 °C, and subsequently beads were washed with the same buffer. Isolated exosomes were analysed by real-time PCR. (6) Exosomal total protein and RNA: exosomal total protein concentration was measured by Pierce Coomassie (Bradford) Protein Assay Kit (ThermoFisher). Exosomal total RNAs and small RNAs were purified using the mirVana miRNA Isolation kit (Life Technologies). Exosomal total RNAs were measured using a Qubit assay (ThermoFisher). Exosomal miRNA analyses. Exosomal miRNAs were analysed according to the following approaches. (1) Exosomal small RNA bioanalyser analysis: exosomal RNAs were run on picoRNA chips or small RNA chips of the Agilent 2100 Bioanalyzer system (Agilent technologies), performed at the Molecular Pathology Platform, Herbert Irving Comprehensive Cancer Center, Columbia University, New York. The exosomal miRNA concentration was calculated according to the instructions provided by Agilent technologies. In brief, the percentage of miRNA in exosomal total RNA was calculated by bioanalyzer picoRNA chips and small RNA chips, and the miRNA concentration was calculated by multiplying percentage of miRNA by the exosomal total RNA measured by Qubit assay (ThermoFisher). (2) miRNA microarray: the miRNA microarray was performed on the GeneChip miRNA 4.0 Array (Affymetrix) at the Albert Einstein College of Medicine Genomics Core using exosomal small RNAs as input. The miRNA pathway analysis was performed using DIANA-mirPath version 3 online software.
(3) miRNA quantitative PCR: miRNA was extracted from purified exosomes or the CSF using the mirVana miRNA isolation kit (Invitrogen) or miRNeasy Mini kit (Qiagen). Extracted miRNAs were reverse transcribed to cDNA using the miRNA first-strand cDNA synthesis kit (Invitrogen or Agilent Technologies), and then subjected to real-time PCR with specific primers and SYBR Green PCR Master Mix (Thermo Fisher Scientific). Secreted growth factor chip array. Cell models of NSCs were cultured in media without EGF and bFGF for two days, and medium was collected and analysed using the Mouse Growth Factor Array (RayBiotech, AAM-GF-2) according to the manufacturer's protocol. Array images were collected and analysed using the LI-COR Odyssey Fc imaging system. Animal models. C57BL/6 mice were obtained from the Jackson Laboratory and the National Institute of Ageing. AgRP-Cre mice and POMC-Cre mice were maintained on a C57BL/6 background as we have previously reported 32, 36 . All mice were kept in standard, infection-free housing conditions, with 12 h light:12 h dark cycles and 4-5 mice per cage. Strictly pathogen-free quality of the mouse colonies was maintained through quarterly serology, quarterly histopathologic exams and daily veterinarian monitoring of the general health and care of animals. All mice in this study were kept on a standard normal chow diet obtained from LabDiet (5001, 4.07 kcal gram −1 ). Only male mice were used in this study. All procedures were approved by the Institutional Animal Care and Use Committee of the Albert Einstein College of Medicine. Hypothalamic lentiviral injection. Purified lentiviruses suspended in 0.2-μ l artificial CSF (aCSF, Tocris Bioscience) were injected bilaterally into the MBH using an ultra-precise stereotactic apparatus (David Kopf Instruments) and the coordinates of 1.7 mm posterior to bregma, 5.8 mm below the surface of the skull, and 0.25 mm lateral to the midline of the brain, via a 26-gauge guide cannula and a 33-gauge internal injector (Plastics One) connected to a 5-μ l Hamilton syringe and infusion pump (WPI Instruments). Lentiviruses suspended in 0.4-μ l aCSF were injected into the hypothalamic third ventricle using the coordinates of 1.7 mm posterior to bregma, 5 mm below the surface of the skull. Guide cannula was implanted into the third ventricle of mice at the coordinate of 1.7 mm posterior to the bregma and 5.0 mm below the surface of skull. Chemical treatment and cell implantation. Mice with MBH injection of the TK1expressing lentivirus were treated with GCV (1-10 μ g in 0.5 μ l aCSF) or vehicle via the pre-implanted third-vehicle cannula, twice per week for the first month (or the experimental duration if less than one month) and then weekly afterwards throughout the experiment. Mice with MBH injection of the DTR-expressing lentivirus were intraperitoneally injected with diphtheria toxin (25 μ g per kg body weight in saline) or the vehicle, twice per week for the indicated duration. For the BrdU-tracking experiment, mice were injected with BrdU (1 μ g in 0.5 μ l aCSF) via the pre-implanted cannula twice per day for one week. Exosome treatment was performed by using exosomes (100 ng protein, purified from cultured htNSCs of newborn mice) three times per week for a duration of 3-4 months as indicated. Cell implantation was performed as described previously 19 . In brief, cultured cells suspended in 0.5 μ l PBS were bilaterally injected into the MBH (9,000 cells each MBH side) using the coordinates of 1.7 mm posterior to bregma, 5.8 mm below the surface of the skull, and 0.25 mm lateral to the midline of the brain via a 26-gauge guide cannula and a 33-gauge internal injector connected to a 5-μ l Hamilton syringe and infusion pump. Behavioural tests. All behaviour tests were performed in the behavioural testing room. An Anymaze video-tracking system (Stoelting) equipped with a digital camera connected to a computer was used for the whole course of animal activities in training and experimental sessions of behavioural tests, including the following tests. (1) The grip test (muscle endurance): as described previously 37 , each mouse was lifted by the tail and placed on a homemade square grid (1-cm mesh size), the grid was then inverted 30 cm over a soft pad, and the mouse was allowed to hang by paws for 2-6 min according to age conditions. The time that the mouse was able to hang was recorded during a 2-min test period. Three repeats were performed for each mouse with at least 10 min rest between each trial. (2) Rotarod test (coordination): mice were trained on a rotarod (Columbus instruments) that was moving at a constant speed of 6 r.p.m. for 60 s. After a 10-min rest, each mouse was given three trials, during which the rotarod started at 6 r.p.m. and accelerated by 2 r.p.m. per min until 10 min, and there was 30-min rest period between each trial. (3) Treadmill: the treadmill test was performed using a Treadmill Simplex II (Columbus Instruments), which has a capacity of exercising up to six mice simultaneously in individual lanes. Mice were warmed up for protection against running injury and failure before experimental running. For acclimatization to the treadmill, the mouse was placed on the treadmill running at a low speed (6 r.p.m.) for 5 min. The test session started at a speed of 8 r.p.m., and the speed was increased by 2 r.p.m. every min for 10 min. The time at which the mouse retired was recorded. (4) Sociality: using a standard procedure as described 38 , social interaction was tested in a grey three-chamber neutral box cage (plexiglas, 60-cm length, 40-cm width, 22-cm height). Before the first session, each mouse was allowed to explore freely for 5 min in the neutral cage to habituate to the testing conditions (adaptation). During the first session (social affiliation), a new mouse (stranger 1) was placed in a wire containment cup that was located in one side chamber. The subject mouse was allowed free access to explore each of the three chambers for 10 min. During the second session (preference), a second new mouse (stranger 2) placed in a wire containment cup was put in the opposite side chamber. The subject mouse freely explored each of the three chambers for 10 min. The time spent in social interaction (sniffing) was recorded. (5) Novel object recognition: the object recognition test was conducted as described 39 . An individual mouse freely explored an open-field box (40 cm length × 40 cm width and × 50 cm height) for 10 min before experimental sessions. During the first session (familiarization session), the mouse was allowed to freely explore two similar objects, and during the second session (test session), one of the two objects was replaced by a novel object for 10 min. The amount of time that the mouse spent exploring each object was recorded. A preference index was calculated using the ratio of the amount of time spent exploring any one of the two objects (including novel one) over the total time spent exploring both objects. (6) The Morris water maze (MWM): the MWM test was performed as described 5 . The water tank was filled with 22-23 °C water, crayola non-toxic paint was added to make opaque and white background, and was located in the centre of a small room with extra-maze cues (various black shapes on a white background). The diameter of the maze was 90 cm and divided into four quadrants (northwest, northeast, southwest and southeast). A circular platform with a diameter of 10 cm was placed 25 cm from the wall of the tank. A mouse was placed in the water, in the same starting location for all trials, and was measured for latency, distance and speed travelled to the platform. Hidden-platform training: mice were first required to swim to and sit on a circular visible platform at 0.5 cm above water level for 10 s. If the mouse could not find the platform within 60 s, it was gently guided to the platform using a glass stirring rod. The mouse was then subjected to four consecutive days of training, consisting of a trial per entry location (entry locations were north, south, east and west) for a total of four trials per day. The platform was made invisible by submerging it 1 cm below the surface of the water. Mice were expected to find the location of the invisible platform, and the following parameters were measured: the latency to reach the platform, distance travelled to reach the platform, path efficiency, time spent in and distance travelled in each quadrant and the total distance and swimming speed. Probe trial: on day 5, the mouse was subjected to a single probe trial, in which the platform was removed and animal was allowed to swim for 60 s. The amount of time spent in all quadrants, the distance and the number of times that the mouse crossed the location of the former platform, as well as the total distance and swimming speed were measured. The learning and memory of mice were indicated positively by occupancy time (the total time spent in the target quadrant) in probe trials. Tissue immunostaining, CSF collection and histology. Mice under anaesthesia were transcardially perfused with 4% PFA, and then the brains were removed, postfixed and infiltrated with 20-30% sucrose. For immunostaining, brain sections with a thickness of 20 μ m were cut using a cryostat, blocked with the serum of the appropriate species, treated with primary antibodies, including mouse anti-Sox2 (R&D Systems, MAB2018), rabbit anti-Sox2 (Millipore, AB5603), mouse anti-Bmi1 (Abcam, ab14389), mouse anti-Nestin (Millipore, MAB353), mouse anti-BrdU (Cell Signaling, 5292), rabbit anti-Ki67 (Abcam, ab15580), rabbit anti-Hsv-TK1 (Santa Cruz, sc-28038), and mouse anti-GFP (Thermo Fisher Scientific, MA1-952) antibodies, and subsequently incubated with AlexaFluor 488 or 555 secondary antibodies. Technical controls for antibody reaction included using naive IgGs of the appropriate species. DAPI staining of sections was used to reveal all cells. For BrdU staining, tissue sections were pre-treated with 2 N HCl for 20 min at 30 °C, washed, followed by incubation with 0.1 M borate buffer for 10 min at room temperature. Fluorescence images of sections were captured using a confocal microscope. Cells of interest in tissue immunostaining were counted in one out of every 3-6 serial sections of the whole target region or a representative subarea, and then the total number of cells was calculated by multiplication according to these factors (which was predicted to be proportional to the actual total number of cells in a 3-dimenstional hypothalamic region). CSF was collected from anaesthetized mice by penetrating a pulled capillary tube into the cisterna magna through the dura mater, as previously described 40 , and the fluid of 3-4 mice was pooled as an individual sample, and the same volume for all samples was used for miRNA analysis. Extra caution was taken to avoid any contamination from the blood or tissue during the procedure of collecting the CSF. For tissue histology, skeletal muscles (quadriceps) and dorsal skin dissected from mice were taken and fixed in 10% neutralized formalin at 4 °C overnight, and subsequently embedded into paraffin. Paraffin sections were then prepared at 5-μ m thickness and subjected to haematoxylin and eosin staining. Optogenetics. According to the established protocol 41 , AgRP-Cre and POMC-Cre mice received a hypothalamic third-ventricle injection of Hsv-TK1 lentiviruses and an intra-MBH bilateral injection of 0.2-μ l rAAV2-FLEX-rev-ChR2:tdTomato viruses (1 × 10 13 genomic copies per ml, produced from Applied Biological Materials Inc.). An Optic/Fluid Cannula (Doric Lenses) was implanted into the hypothalamic third ventricle of mice at the coordinates of 1.7 mm posterior to the bregma and 5 mm below the surface of the skull. Mice received GCV treatment through the implanted cannula. During the experiment, light from a diode laser (450 nm, Doris Lenses) was delivered to the brain via an optic fibre (0.22 NA, 200 μ m core; Doric Lenses), as previously described 41 , including 20 light pulses (10 ms each) for 1 s (20 Hz) followed by a 3-s break, and the sequence was repeated for 1 h in AgRP-Cre mice and 24 h in POMC-Cre mice. The optogenetic stimulation-induced feeding response was assessed by measuring food intake during various time intervals. 
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